{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:21:49Z","timestamp":1790619709265,"version":"4.1.0"},"reference-count":29,"publisher":"Europa Digital & Publishing","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.4244\/eijy14m05_03","type":"journal-article","created":{"date-parts":[[2015,5,17]],"date-time":"2015-05-17T18:14:09Z","timestamp":1431886449000},"page":"1383-1390","source":"Crossref","is-referenced-by-count":32,"title":["Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial"],"prefix":"10.4244","volume":"10","author":[{"given":"William","family":"Wijns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Vrolix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Verheye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Schoors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton","family":"Slagboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Gosselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Benit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Donohoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Knape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme F.","family":"Attizzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Lansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ormiston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2774","reference":[{"key":"key-201551719120-0","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jacc.2005.07.071","article-title":"Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.","volume":"47","author":"Nebeker JR.","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"key-201551719120-1","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","article-title":"Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.","volume":"115","author":"Camenzind E.","year":"2007","journal-title":"Circulation."},{"key":"key-201551719120-2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/01.CIR.0000153356.72810.97","article-title":"Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents.","volume":"111","author":"Mauri L.","year":"2005","journal-title":"Circulation."},{"key":"key-201551719120-3","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip DE.","year":"2007","journal-title":"Circulation."},{"key":"key-201551719120-4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jconrel.2012.07.004","article-title":"Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug.","volume":"162","author":"Carlyle WC.","year":"2012","journal-title":"J Control Release."},{"key":"key-201551719120-5","first-page":"157","article-title":"First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary lesions: Endeavor I Trial.","volume":"1","author":"Meredith IT.","year":"2005","journal-title":"EuroIntervention."},{"key":"key-201551719120-6","doi-asserted-by":"publisher","first-page":"45M","DOI":"10.1016\/j.amjcard.2007.08.021","article-title":"Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients.","volume":"100","author":"Gershlick A.","year":"2007","journal-title":"Am J Cardiol."},{"key":"key-201551719120-7","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jcin.2013.05.013","article-title":"First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).","volume":"6","author":"Ormiston J.","year":"2013","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201551719120-8","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.jcin.2009.06.019","article-title":"Intracoronary optical coherence tomography: a comprehensive review.","volume":"2","author":"Bezerra HG.","year":"2009","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201551719120-9","first-page":"560","article-title":"Serial Evaluation of Vascular Response After Implantation of a New Sirolimus-Eluting Stent With Bioabsorbable Polymer (MISTENT): an optical coherence tomography and histopathological study.","volume":"24","author":"Attizzani GF.","year":"2012","journal-title":"J Invasive Cardiol."},{"key":"key-201551719120-10","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.amjcard.2013.07.013","article-title":"Serial assessment by optical coherence tomography of early and late vascular responses after implantation of an absorbable-coating Sirolimus-Eluting stent (from the first-in-human DESSOLVE I trial).","volume":"112","author":"Attizzani GF.","year":"2013","journal-title":"Am J Cardiol."},{"key":"key-201551719120-11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10554-010-9793-y","article-title":"Assessment of coronary stent by optical coherence tomography, methodology and definitions.","volume":"27","author":"Mehanna EA.","year":"2011","journal-title":"Int J Cardiovasc Imaging."},{"key":"key-201551719120-12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4244\/EIJV5I2A35","article-title":"Reproducibility of quantitative optical coherence tomography for stent analysis.","volume":"5","author":"Gonzalo N.","year":"2009","journal-title":"EuroIntervention."},{"key":"key-201551719120-13","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.amjcard.2006.01.031","article-title":"Assessment of coronary arterial thrombus by optical coherence tomography.","volume":"97","author":"Kume T.","year":"2006","journal-title":"Am J Cardiol."},{"key":"key-201551719120-14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCULATIONAHA.107.749564","article-title":"Images in cardiovascular medicine. Fibrin clot visualized by optical coherence tomography.","volume":"118","author":"Kume T.","year":"2008","journal-title":"Circulation."},{"key":"key-201551719120-15","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.jacc.2011.10.909","article-title":"In-stent neoatherosclerosis: a final common pathway of late stent failure.","volume":"59","author":"Park SJ.","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-201551719120-16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jcin.2012.12.125","article-title":"Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents.","volume":"6","author":"Kandzari DE.","year":"2013","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201551719120-17","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jcin.2012.04.008","article-title":"3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents.","volume":"5","author":"Maeng M.","year":"2012","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201551719120-18","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jacc.2004.11.063","article-title":"Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial.","volume":"45","author":"Ellis SG.","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"key-201551719120-19","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1136\/heartjnl-2012-302519","article-title":"Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomised trials versus other limus-eluting stents and an adjusted indirect comparison.","volume":"98","author":"Cassese S.","year":"2012","journal-title":"Heart."},{"key":"key-201551719120-20","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.amjcard.2011.06.037","article-title":"Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy).","volume":"108","author":"Maeng M.","year":"2011","journal-title":"Am J Cardiol."},{"key":"key-201551719120-21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/ccd.24512","article-title":"Everolimus-eluting stents and zotarolimus-eluting stents for percutaneous coronary interventions: two-year outcomes in New York State.","volume":"81","author":"Hannan EL.","year":"2013","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-201551719120-22","doi-asserted-by":"publisher","first-page":"f6625","DOI":"10.1136\/bmj.f6625","article-title":"Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.","volume":"347","author":"Bangalore S.","year":"2013","journal-title":"BMJ."},{"key":"key-201551719120-23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1161\/CIRCINTERVENTIONS.108.797928","article-title":"Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses.","volume":"1","author":"Hamilos M.","year":"2008","journal-title":"Circ Cardiovasc Interv."},{"key":"key-201551719120-24","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jcin.2011.04.007","article-title":"Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: the LongOCT study (Optical Coherence Tomography in Long Lesions).","volume":"4","author":"Guagliumi G.","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201551719120-25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1161\/CIRCINTERVENTIONS.111.965582","article-title":"Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography.","volume":"5","author":"Guagliumi G.","year":"2012","journal-title":"Circ Cardiovasc Interv."},{"key":"key-201551719120-26","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/ccd.24374","article-title":"Impact of different stent alloys on human vascular response to everolimus-eluting stent: an optical coherence tomography study: the OCTEVEREST.","volume":"81","author":"Guagliumi G.","year":"2013","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-201551719120-27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcin.2011.09.018","article-title":"Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging.","volume":"5","author":"Guagliumi G1.","year":"2012","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201551719120-28","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.jacc.2014.01.019","article-title":"Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition.","volume":"63","author":"Attizzani GF.","year":"2014","journal-title":"J Am Coll Cardiol."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2015,5,17]],"date-time":"2015-05-17T18:14:18Z","timestamp":1431886458000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/83rd_issue\/241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["20130909-01"],"URL":"https:\/\/doi.org\/10.4244\/eijy14m05_03","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}